The study of microvascular endothelial cells (MVECs) is crucial for understanding various physiological and pathological processes, including angiogenesis, inflammation, and tumor progression. This article describes a methodology employing the transfection of MVECs isolated from human foreskins with the pSVT vector, a plasmid that encodes the Simian virus 40 (SV40) large T antigen. The SV40 large T antigen is instrumental in cell cycle regulation, and its expression in MVECs can provide insights into endothelial biology and cancer research.

Introduction

Microvascular endothelial cells are essential components of the vascular system, forming the inner lining of blood vessels and playing a significant role in regulating vascular permeability, leukocyte trafficking, and angiogenesis. Isolating these cells from human tissues allows for the exploration of their physiological roles and responses to various stimuli. The pSVT vector, derived from pBR-322, is widely used in genetic engineering to express foreign genes. This vector is particularly notable for its ability to stably express the SV40 large T antigen, which has been shown to induce transformation in various cell types.

Materials and Methods

Isolation of Microvascular Endothelial Cells
Human foreskin tissues were obtained and processed to isolate MVECs. The tissues were enzymatically digested to release the cells, which were then cultured in specific media conditions conducive to endothelial growth.

Transfection with pSVT Vector

1. Plasmid Preparation: The pSVT vector, containing the coding sequence for the SV40 large T antigen, was prepared in bacterial culture and purified using a plasmid purification kit.

2. Transfection Procedure: MVECs were transfected using a lipofection method. Cells were incubated with the pSVT vector in a transfection reagent under optimal conditions to facilitate the uptake of the plasmid.

3. Selection of Transfected Cells: Following the transfection process, cells were subjected to selection using an appropriate antibiotic to enrich for those successfully incorporated with the pSVT vector.

4. Verification of Transfection: The expression of large T antigen was confirmed through techniques such as Western blot analysis and immunofluorescence microscopy.

Results

Following transfection with the pSVT vector, a significant proportion of MVECs exhibited expression of the SV40 large T antigen. The successful expression was evidenced by increased cell proliferation rates and alterations in cell cycle dynamics, characteristic of cells expressing oncogenic factors.

Discussion

The expression of large T antigen in MVECs provides a valuable model for studying the regulatory mechanisms of endothelial cell behavior under conditions that resemble tumor microenvironments. The findings suggest that the activation of specific signaling pathways by large T antigen may lead to enhanced angiogenic properties in MVECs, contributing to our understanding of tumor-induced angiogenesis.

Moreover, this study highlights the utility of the pSVT vector in transfecting primary human cells, opening avenues for further research into the manipulation of endothelial cell function through genetic engineering.

Conclusion

Transfecting microvascular endothelial cells with the pSVT vector for the expression of SV40 large T antigen is a promising approach to elucidate the roles of endothelial cells in various biological contexts. Future studies will focus on the functional implications of large T antigen expression and its potential as a target for therapeutic strategies in cancer and other diseases involving abnormal angiogenesis.